CARDINAL HEALTH, INC. for CARDINAL HEALTH INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Changes to the House and Senate National Defense Authorization Acts, Section 801 regarding federal contracting - implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Alcohol and Drug Abuse ALC
General issues regarding prescription drug abuse
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Disaster Planning/Emergencies DIS
S. 3548 CARES Act COVID 19/H.R. 748 CARES Act; Issues related to COVID 19 response
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Health Issues HCR
Issues related to the RFI on the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Civil Rights/Civil Liberties CIV
Equality Act, H.R. 5
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Energy/Nuclear ENG
American Medical Isotopes Production Act of 2012: Section 2: Improving the Reliability of Domestic Medical Isotope Supply- implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Tariff (miscellaneous tariff bills) TAR
Exclusion of health care related products in proposed section 301 tariffs. Educate on potential impact of tariffs on goods from Mexico.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Medical/Disease Research/Clinical Labs MED
H.R. 1865, Further Consolidated Appropriations Act, 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.